GENETICALLY-DETERMINED OXIDATION CAPACITY AND THE DISPOSITION OF DEBRISOQUINE

被引：59

作者：

SLOAN, TP

LANCASTER, R

SHAH, RR

IDLE, JR

SMITH, RL

机构：

来源：

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1983年 / 15卷 / 04期

关键词：

D O I：

10.1111/j.1365-2125.1983.tb01528.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：443 / 450

页数：8

共 16 条

[1] PHARMACOGENETIC COVARIATION OF DEFECTIVE N-OXIDATION OF SPARTEINE AND 4-HYDROXYLATION OF DEBRISOQUINE [J].

BERTILSSON, L ;

DENGLER, HJ ;

EICHELBAUM, M ;

SCHULZ, HU .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 17 (02) :153-155

[2] KINETIC CONSIDERATIONS RELATING TO ACCRUAL AND ELIMINATION OF DRUG METABOLITES [J].

CUMMINGS, AJ ;

MARTIN, BK ;

PARK, GS .

BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY, 1967, 29 (02) :136-&

[3]

DANHOF M, 1980, THESIS U LEIDEN

[4] GAS-LIQUID-CHROMATOGRAPHIC ELECTRON-CAPTURE DETERMINATION OF SOME MONOSUBSTITUTED GUANIDO-CONTAINING DRUGS [J].

ERDTMANSKY, P ;

GOEHL, TJ .

ANALYTICAL CHEMISTRY, 1975, 47 (04) :750-752

[5] A FAMILY AND POPULATION STUDY OF THE GENETIC-POLYMORPHISM OF DEBRISOQUINE OXIDATION IN A WHITE BRITISH-POPULATION [J].

EVANS, DAP ;

MAHGOUB, A ;

SLOAN, TP ;

IDLE, JR ;

SMITH, RL .

JOURNAL OF MEDICAL GENETICS, 1980, 17 (02) :102-105

[6]

IDLE JR, 1981, BRIT J CLIN PHARMACO, V11, pP418

[7] HYPOTENSIVE RESPONSE TO DEBRISOQUINE AND HYDROXYLATION PHENOTYPE [J].

IDLE, JR ;

MAHGOUB, A ;

LANCASTER, R ;

SMITH, RL .

LIFE SCIENCES, 1978, 22 (11) :979-983

[8] METABOLISM OF [C-14]-DEBRISOQUINE IN MAN [J].

IDLE, JR ;

MAHGOUB, A ;

ANGELO, MM ;

DRING, LG ;

LANCASTER, R ;

SMITH, RL .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 7 (03) :257-266

[9]

LEVY GL, 1972, CLIN PHARMACOL THER, V13, P258

[10] POLYMORPHIC HYDROXYLATION OF DEBRISOQUINE IN MAN [J].

MAHGOUB, A ;

IDLE, JR ;

DRING, LG ;

LANCASTER, R ;

SMITH, RL .

LANCET, 1977, 2 (8038) :584-586

← 1 2 →